Be part of the knowledge.™

Rare and Orphan Diseases

475

LikeLikedUnlike

16-23 of 23

Investigator Interview: Treating Rapidly Progressing Patients with ADPKD
CME/CE
Investigator Interview: Treating Rapidly Progressing Patients with ADPKD
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
CME/CE
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
- Jennifer Caudle, DO
  Peer
- Mikkael A. Sekeres, MD, MS
  Peer
- Sara M. Tinsley, PhD, ARNP, AOCNP
  Peer
0.50 credits
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies
CME/CE
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies
- Arlene B. Chapman, MD
  Peer
- Michel Chonchol, MD
  Peer
0.50 credits
A Patient's Journey with ADPKD
CME/CE
A Patient's Journey with ADPKD
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 3: Management
CME/CE
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 3: Management
- Michel Chonchol, MD
  Peer
- Frederic Rahbari-Oskoui, MD, MSc
  Peer
0.50 credits
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 2: Progression and Prognostication
CME/CE
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 2: Progression and Prognostication
- Matthew B. Lanktree, MD, PhD
  Peer
- Neera Dahl, MD, PhD
  Peer
0.50 credits
advertisement
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 1: Detection and Diagnosis
CME/CE
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 1: Detection and Diagnosis
- Arlene B. Chapman, MD
  Peer
- Matthew B. Lanktree, MD, PhD
  Peer
0.50 credits
The Clinical Significance of Imaging in the Management of ADPKD
CME/CE
The Clinical Significance of Imaging in the Management of ADPKD
- Jimmy T. Lee, MD
  Peer
- Arlene B. Chapman, MD
  Peer
0.75 credits

Program Chapters

Segment Chapters

Playlist:

Recommended